Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

As pet owners, we dread the day our companions show signs of illness, but a vet has explained everything you need to know.

Las Palmas captain Kirian Rodriguez has revealed will stop playing for six months following confirmation that his Hodgkin ...

Canadian Cancer Society reports draw attention to the disease’s financial burden on patients, which includes the toll of ...